NMPA Approval

Pasireotide Diaspartate Injection

Approval Number

H20150316

Registration Date

July 3, 2019

Previous Approval Numbers

H20150316

Drug Information

Generic Name

门冬氨酸帕瑞肽注射液

Trade Name

丝尼芬

Dosage Form

注射剂

Strength

1ml:0.3mg(以帕瑞肽计)

Drug Type

化学药品

Registration Date

July 3, 2019

Expiry Date

May 26, 2020

Company Address

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

Company Address

Schaffhauserstrasse 4332 Stein，Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

门冬氨酸帕瑞肽注射液 - NMPA 批准文号 | MedPath